Chondrocytes-Specific Expression of Osteoprotegerin Modulates Osteoclast Formation in Metaphyseal Bone

Scientific Reports - United Kingdom
doi 10.1038/srep13667
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Osteoprotegerin Ligand Modulates Murine Osteoclast Survival in Vitro and in Vivo

American Journal of Pathology
Forensic MedicinePathology
2000English

Osteoprotegerin Ligand and Osteoprotegerin: Novel Implications for Osteoclast Biology and Bone Metabolism

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1999English

NFAM1 Signaling Enhances Osteoclast Formation and Bone Resorption Activity in Paget's Disease of Bone

Bone
EndocrinologyPhysiologyHistologyMetabolismDiabetes
2017English

Disruption of Glucocorticoid Signaling in Chondrocytes Delays Metaphyseal Fracture Healing but Does Not Affect Normal Cartilage and Bone Development

Bone
EndocrinologyPhysiologyHistologyMetabolismDiabetes
2014English

Osteoblast-Osteoclast Co-Culture Amplifies Inhibitory Effects of FG-4592 on Osteoclast Formation and Reduces Bone Resorption Activity

2019English

Bone Morphogenetic Protein-2 Enhances WNT/Β-Catenin Signaling-Induced Osteoprotegerin Expression

Genes to Cells
MedicineGeneticsCell Biology
2009English

Oxidation-Specific Epitopes Restrain Bone Formation

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Methothrexate Directly Inhibits RANKL Expression and Osteoclast Formation in Very Early Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2010English

TNF-α Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation

Frontiers in Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy